Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease

doi:10.4239/wjd.v15.i7.1562

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (808)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-11) series, Tables (1-6) series.

Item

Count

PDF

HTML

549

Figures (1-11)

Tables (1-6)

Sum=677

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=80

Jul 15, 2024 (publication date) through Aug 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Diabetes. Jul 15, 2024; 15(7): 1562-1588
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1562

Full Size Figure Download Figure

Figure 9 Docking result diagram. A: Obacunone-mitogen-activated protein kinase 3 (MAPK3); B: Obacunone-AKT serine/threonine kinase 1 (AKT1); C: Obacunone-heat shock protein 90 alpha family class A member 1 (HSP90AA1); D: Quercetin-tumor necrosis factor (TNF); E: Quercetin-AKT serine/threonine kinase 1 (AKT1); F: Quercetin-epidermal growth factor receptor (EGFR); G-L: The different types of two-dimensional bonding modes, respectively.

Citation: Zhang MY, Zheng SQ. Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease. World J Diabetes 2024; 15(7): 1562-1588
URL: https://www.wjgnet.com/1948-9358/full/v15/i7/1562.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i7.1562